查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1428206

2024 年腫瘤學和免疫學流式細胞技術全球市場報告

Flow Cytometry In Oncology And Immunology Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

流式細胞技術在腫瘤學和免疫學領域的市場規模預計在未來幾年將快速成長。預計到 2028 年將以 10.0% 的複合年成長率 (CAGR) 成長至 30.7 億美元。預測期內的預期成長可歸因於基因組學和蛋白​​質組學的整合、單細胞分析的日益採用、感染疾病應用的擴大、癌症發病率的增加以及照護現場流式細胞技術。預測期內預計出現的顯著趨勢包括免疫治療的免疫表現型分析、流式細胞技術系統的小型化、多參數分析、向頻譜流式細胞技術的過渡以及合作研究舉措。

癌症發生率的預期增加預計將推動流式細胞技術在腫瘤學和免疫學領域的發展。癌症是一組以不受控制的細胞增殖為特徵的疾病，是流式細胞技術在癌症和免疫細胞研究中的重要關注領域。例如，麥克米倫癌症支持組織在2022 年10 月報告稱，2020 年將有約300 萬人受到癌症影響，預計到2025 年將達到350 萬人，到2030 年將達到400 萬人，預計到2040年這數字將增至530 萬人。這是推動流式細胞技術在腫瘤學和免疫學領域發展的關鍵因素。

愛滋病毒/愛滋病的日益流行預計將有助於腫瘤學和免疫學領域流式細胞技術市場的擴大。愛滋病毒是一種影響免疫系統並造成全球健康問題的病毒。流式細胞技術透過分析細胞，特別是免疫細胞的物理和化學特性，在愛滋病毒/愛滋病研究和臨床應用中發揮重要作用。截至 2023 年 7 月，世界衛生組織報告稱，到 2022 年，將有約 3,900 萬人感染愛滋病毒，估計範圍為 3,310 萬至 4,570 萬人。同一時期，約 63 萬人死於愛滋病毒相關原因，信賴區間為 48 萬至 88 萬。此外，2022年，約有130萬人感染愛滋病毒，範圍在100萬至170萬之間。因此，愛滋病毒/愛滋病盛行率的上升是流式細胞技術在腫瘤學和免疫學領域發展的關鍵驅動力。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球流式細胞技術在腫瘤學和免疫學市場的促進因素和阻礙因素
    • 市場驅動力
    • 市場限制
  • 全球流式細胞技術在腫瘤學和免疫學市場規模、表現和成長，2018-2023
  • 全球腫瘤學及免疫學流式細胞技術儀市場規模及成長預測，2023-2028、2033

第6章市場區隔

  • 全球腫瘤學和免疫學中的流式細胞技術，按類型、性能和預測細分，2018-2023、2023-2028、2033
  • 免疫學
  • 腫瘤學
  • 全球腫瘤學和免疫學中的流式細胞技術，按技術、性能和預測細分，2018-2023、2023-2028、2033
  • 基於細胞的
  • 以微珠為基礎
  • 流式細胞技術在全球腫瘤學和免疫學的應用、性能和預測細分，2018-2023、2023-2028、2033
  • 轉化研究
  • 臨床調查
  • 全球腫瘤學和免疫學中的流式細胞技術，最終用戶的細分、性能和預測，2018-2023、2023-2028、2033
  • 醫院
  • 診斷實驗室
  • 參考實驗室
  • 製藥和生物技術公司
  • 學術研究所
  • 合約研究組織
  • 其他最終用戶

第 7 章 區域與國家分析

  • 流式細胞技術在全球腫瘤學和免疫學中的應用，按地區、性能和預測，2018-2023、2023-2028、2033
  • 流式細胞技術在全球腫瘤學和免疫學中的應用，按國家、性能和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 流式細胞技術在腫瘤學和免疫學領域的競爭形勢
  • 腫瘤學和免疫學流式細胞技術公司簡介
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Becton Dickinson and Company
    • Laboratory Corporation of America Holdings

第31章 其他大型創新公司

  • Agilent Technologies Inc.
  • Sartorius AG
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Sysmex Partec GmbH
  • OPKO Health Inc.
  • Miltenyi Biotec
  • NeoGenomics Laboratories Inc.
  • Luminex Corporation
  • Q2 Solutions LLC
  • Enzi Biochem Inc.
  • DiaSorin SpA
  • BioLegend Inc.
  • Cytek Biosciences Inc.
  • Cell Signaling Technology Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r14050

Flow cytometry, as applied in oncology and immunology, denotes a technology and methodology utilized to analyze and characterize cells based on their physical and chemical attributes.

The primary categories of flow cytometry in oncology and immunology encompass immunology and oncology. Immunology, a field within biomedical science, explores the immune system and its reactions to foreign substances referred to as antigens. Within the realms of oncology and immunology, flow cytometry involves diverse technologies, including cell-based flow cytometry and bead-based flow cytometry. These technologies find applications in various contexts such as translational research and clinical research. The end users of flow cytometry in this context encompass hospitals, diagnostic laboratories, reference laboratories, pharmaceutical and biotechnology companies, academic research institutes, contract research organizations, among others.

The flow cytometry in oncology and immunology research report is one of a series of new reports from The Business Research Company that provides flow cytometry in oncology and immunology market statistics, including the flow cytometry in oncology and immunology industry's global market size, regional shares, competitors with flow cytometry in oncology and immunology market share, detailed flow cytometry in oncology and immunology market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry in oncology and immunology industry. This flow cytometry in oncology and immunology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The flow cytometry in oncology and immunology market size has grown rapidly in recent years. It will grow from $1.89 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historical period can be credited to progress in cancer research, expansion in immunology research, diagnostic applications, an increase in autoimmune diseases, and the undertaking of drug development and clinical trials.

The flow cytometry in oncology and immunology market size is expected to see rapid growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The anticipated growth in the forecast period can be ascribed to the integration with genomics and proteomics, the increasing adoption of single-cell analysis, the broadening applications in infectious diseases, the rise in cancer incidence, and the emergence of point-of-care flow cytometry. Notable trends expected in the forecast period include immunophenotyping for immunotherapy, the miniaturization of flow cytometry systems, multiparametric analysis, a shift towards spectral flow cytometry, and collaborative research initiatives.

The anticipated rise in cancer prevalence is poised to drive the growth of flow cytometry in the oncology and immunology market. Cancer, a group of disorders characterized by uncontrolled cell growth, is a significant area of focus for flow cytometry in studying cancer and immune cells. For example, Macmillan Cancer Support reported in October 2022 that approximately 3 million people had cancer in 2020, and projections estimate an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Hence, the increasing prevalence of cancer is a key factor propelling the growth of flow cytometry in the oncology and immunology markets.

The growing prevalence of HIV/AIDS is expected to contribute to the expansion of the flow cytometry market in oncology and immunology. HIV, a virus affecting the immune system, poses a global health challenge. Flow cytometry plays a crucial role in HIV/AIDS research and clinical applications by analyzing cells, especially immune cells, based on their physical and chemical properties. As of July 2023, the World Health Organization reported that approximately 39.0 million individuals were living with HIV in 2022, with an estimated range of 33.1 to 45.7 million. During the same period, around 630,000 people died due to HIV-related causes, with a confidence interval of 480,000 to 880,000. Moreover, approximately 1.3 million people contracted HIV in 2022, with a range of 1.0 to 1.7 million. Thus, the rising prevalence of HIV/AIDS is a significant driver for the growth of flow cytometry in the oncology and immunology market.

Technological advancements stand out as a prominent trend gaining traction in the flow cytometry market for oncology and immunology. Major players in this market are actively embracing innovative technologies to solidify their market positions. For example, in September 2022, Becton Dickinson and Company, a US-based medical technology provider, introduced the BD Research Cloud tailored for flow cytometry applications in oncology and immunology. This cloud-based software simplifies the flow cytometry process for researchers in fields such as immunology, virology, infectious disease, and oncology surveillance. Leveraging technologies such as BD Horizon RealYellow and RealBlue Reagents, along with the BD FACSDiscover S8 Cell Sorter featuring BD CellView Image Technology, BD aims to enhance flow cytometry capabilities, enabling researchers to optimize and advance their studies. BD Research Cloud, built on an industry-standard cloud infrastructure, is designed to complement BD equipment and reagents.

Companies in the flow cytometry market for oncology and immunology are also concentrating on innovative solutions such as automated sample preparation systems. An automated sample preparation system streamlines and automates various steps involved in preparing samples for analysis. For instance, in March 2022, Beckman Coulter Life Sciences, a US-based life science company, unveiled 'CellMek SPS,' a fully automated sample preparation system designed for clinical flow cytometry. This system offers on-demand processing for diverse sample types, enabling laboratories to expand their capabilities. CellMek SPS, building on a robust history of lab automation, integrates features that enhance efficiency by automating outdated manual preparation methods. This innovative system ensures a seamless workflow, delivering a continuous output of samples ready for analysis with complete traceability.

In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, completed the acquisition of Luminex Corporation for $1.8 billion. This strategic move by DiaSorin S.p.A. aims to strengthen its existing portfolio in the life science sector, fostering access to academic and scientific research, expanding collaboration with biopharma businesses, and enhancing overall market presence. Luminex Corporation, a US-based biotechnology company, specializes in providing flow cytometry solutions for oncology and immunology.

Major companies operating in the flow cytometry in oncology and immunology market report are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, Enzi Biochem Inc., DiaSorin S.p.A,BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason.

North America was the largest region in the flow cytometry in oncology and immunology market in 2023. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the flow cytometry in oncology and immunology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The flow cytometry in oncology and immunology market includes revenues earned by entities by providing services such as cell-based assay services, drug development services, and minimal residual disease (MRD) monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The flow cytometry in oncology and immunology market also consists of sales of products flow cytometers, fluorescence-activated cell sorters (FACS), monoclonal antibodies, and fluorochromes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Flow Cytometry In Oncology And Immunology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on flow cytometry in oncology and immunology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for flow cytometry in oncology and immunology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The flow cytometry in oncology and immunology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Immunology; Oncology
  • 2) By Technology: Cell-Based Flow Cytometry; Bead-Based Flow Cytometry
  • 3) By Application: Translational Research; Clinical Research
  • 4) By End User: Hospitals; Diagnostic Laboratories; Reference Laboratories; Pharmaceutical And Biotechnology Companies; Academic Research Institutes; Contract Research Organizations; Other End Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton Dickinson and Company; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Flow Cytometry In Oncology And Immunology Market Characteristics

3. Flow Cytometry In Oncology And Immunology Market Trends And Strategies

4. Flow Cytometry In Oncology And Immunology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Flow Cytometry In Oncology And Immunology Market Size and Growth

  • 5.1. Global Flow Cytometry In Oncology And Immunology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Flow Cytometry In Oncology And Immunology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Flow Cytometry In Oncology And Immunology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Flow Cytometry In Oncology And Immunology Market Segmentation

  • 6.1. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunology
  • Oncology
  • 6.2. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell-Based Flow Cytometry
  • Bead-Based Flow Cytometry
  • 6.3. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Translational Research
  • Clinical Research
  • 6.4. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Reference Laboratories
  • Pharmaceutical And Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Other End Users

7. Flow Cytometry In Oncology And Immunology Market Regional And Country Analysis

  • 7.1. Global Flow Cytometry In Oncology And Immunology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Flow Cytometry In Oncology And Immunology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Flow Cytometry In Oncology And Immunology Market

  • 8.1. Asia-Pacific Flow Cytometry In Oncology And Immunology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Flow Cytometry In Oncology And Immunology Market

  • 9.1. China Flow Cytometry In Oncology And Immunology Market Overview
  • 9.2. China Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Flow Cytometry In Oncology And Immunology Market

  • 10.1. India Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Flow Cytometry In Oncology And Immunology Market

  • 11.1. Japan Flow Cytometry In Oncology And Immunology Market Overview
  • 11.2. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Flow Cytometry In Oncology And Immunology Market

  • 12.1. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Flow Cytometry In Oncology And Immunology Market

  • 13.1. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Flow Cytometry In Oncology And Immunology Market

  • 14.1. South Korea Flow Cytometry In Oncology And Immunology Market Overview
  • 14.2. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Flow Cytometry In Oncology And Immunology Market

  • 15.1. Western Europe Flow Cytometry In Oncology And Immunology Market Overview
  • 15.2. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Flow Cytometry In Oncology And Immunology Market

  • 16.1. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Flow Cytometry In Oncology And Immunology Market

  • 17.1. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Flow Cytometry In Oncology And Immunology Market

  • 18.1. France Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Flow Cytometry In Oncology And Immunology Market

  • 19.1. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Flow Cytometry In Oncology And Immunology Market

  • 20.1. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Flow Cytometry In Oncology And Immunology Market

  • 21.1. Eastern Europe Flow Cytometry In Oncology And Immunology Market Overview
  • 21.2. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Flow Cytometry In Oncology And Immunology Market

  • 22.1. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Flow Cytometry In Oncology And Immunology Market

  • 23.1. North America Flow Cytometry In Oncology And Immunology Market Overview
  • 23.2. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Flow Cytometry In Oncology And Immunology Market

  • 24.1. USA Flow Cytometry In Oncology And Immunology Market Overview
  • 24.2. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Flow Cytometry In Oncology And Immunology Market

  • 25.1. Canada Flow Cytometry In Oncology And Immunology Market Overview
  • 25.2. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Flow Cytometry In Oncology And Immunology Market

  • 26.1. South America Flow Cytometry In Oncology And Immunology Market Overview
  • 26.2. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Flow Cytometry In Oncology And Immunology Market

  • 27.1. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Flow Cytometry In Oncology And Immunology Market

  • 28.1. Middle East Flow Cytometry In Oncology And Immunology Market Overview
  • 28.2. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Flow Cytometry In Oncology And Immunology Market

  • 29.1. Africa Flow Cytometry In Oncology And Immunology Market Overview
  • 29.2. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Flow Cytometry In Oncology And Immunology Market Competitive Landscape And Company Profiles

  • 30.1. Flow Cytometry In Oncology And Immunology Market Competitive Landscape
  • 30.2. Flow Cytometry In Oncology And Immunology Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Danaher Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Flow Cytometry In Oncology And Immunology Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Sartorius AG
  • 31.3. Beckman Coulter Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Sysmex Partec GmbH
  • 31.6. OPKO Health Inc.
  • 31.7. Miltenyi Biotec
  • 31.8. NeoGenomics Laboratories Inc.
  • 31.9. Luminex Corporation
  • 31.10. Q2 Solutions LLC
  • 31.11. Enzi Biochem Inc.
  • 31.12. DiaSorin S.p.A
  • 31.13. BioLegend Inc.
  • 31.14. Cytek Biosciences Inc.
  • 31.15. Cell Signaling Technology Inc.

32. Global Flow Cytometry In Oncology And Immunology Market Competitive Benchmarking

33. Global Flow Cytometry In Oncology And Immunology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Flow Cytometry In Oncology And Immunology Market

35. Flow Cytometry In Oncology And Immunology Market Future Outlook and Potential Analysis

  • 35.1 Flow Cytometry In Oncology And Immunology Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Flow Cytometry In Oncology And Immunology Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Flow Cytometry In Oncology And Immunology Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer